Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
Clinical trial NCT02157987 · COMPLETED
Trial details
- NCT number
- NCT02157987
- Sponsor
- University Hospital, Caen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-15
- Primary completion
- 2020-10-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.